Viibryd Side Effects: Weight Loss or Weight Gain? The Food and Drug Administration (FDA) has recently approved Viibryd (vilazodone hydrochloride) to treat adults suffering from major depressive disorder.
As we usually do here at Health Care Zone, we’d like to focus on the side effects of this newly approved drug and this is what the FDA says about the matter: “The most frequent adverse reactions reported by patients taking Viibryd in clinical trials included diarrhea, nausea, vomiting, and insomnia… Viibryd and all other antidepressant drugs have a boxed warning and a patient medication guide describing the increased risk of suicidal thinking and behavior in children, adolescents, and young adults ages 18 to 24 during initial treatment.”
Viibryd, manufactured by PGxHealth in New Haven, Connecticut, will be made available in 10, 20 and 40 milligram tablets.
Continue reading “Viibryd Side Effects: Weight Loss or Weight Gain?”
